Which class of drugs treats allergic rhinitis by inhibiting histamine release?

• A. Antihistamines
• B. Beta-agonists
• C. Corticosteroids
• D. Leukotriene antagonists

Answer: (A)

Antihistamines are specifically designed to counteract the effects of histamine, a chemical released during allergic reactions, which leads to symptoms such as sneezing, itching, and nasal congestion associated with allergic rhinitis. By blocking histamine receptors, particularly the H1 receptor, antihistamines help alleviate these symptoms by preventing histamine from exerting its effects.

In the context of the other classifications, beta-agonists are primarily used for respiratory conditions like asthma and act by stimulating beta-adrenergic receptors, providing bronchodilation rather than directly affecting histamine release. Corticosteroids reduce inflammation and immune response but do not primarily prevent histamine release; instead, they modulate the overall allergic response. Leukotriene antagonists help manage allergic rhinitis and asthma by blocking leukotriene receptors, which can also contribute to inflammation and bronchoconstriction, but they do not target histamine directly. Thus, antihistamines are the most appropriate choice for treating allergic rhinitis by directly inhibiting the effects of histamine.